Next Frontiers to Cure Cancer
  1. Início
  2. Convidados

Convidado

ASAF ZVIRAN

ASAF ZVIRAN

UNITED KINGDOM

Asaf Zviran is the co-founder, CEO and CSO of C2i Genomics, a company that advances personalized cancer drug development and treatment by providing vital real-time cancer detection and monitoring at a global scale. Dr. Zviran lead the company development from Academy research concept to VC-backed growth-stage company. 

Imprimir

Atividades

23/06/2022

10:40 às 12:00 - Insights in Cancer Research - Session II - Circulating tumor DNA: Current and Future applications

10:40 às 11:10 - Ultra-sensitive detection and monitoring of solid cancers using whole-genome mutation integration

Palestrante

Voltar